Read + Share
Amedeo Smart
Independent Medical Education
Thethi TK, Pratley R, Meier JJ. Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme. Diabetes Obes Metab 2020 Apr 8. doi: 10.1111/dom.14054.PMID: 32267058
Email
LinkedIn
Facebook
Twitter
Privacy Policy